Procarbazine (Matulane (US) Natulan (Canada) Indicarb (India) is an antineoplastic chemotherapy drug for the treatment of Hodgkin’s lymphoma and certain brain cancers (such as glioblastoma multiforme). It is a member of a group of medicines called alkylating agents. It gained FDA Approved in July 1969. The drug is metabolized and activated in the liver.
This page contains content from the copyrighted Wikipedia article "Procarbazine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
